Sort by
Refine Your Search
-
Category
-
Employer
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- BIOGIPUZKOA HEALTH RESEARCH INSTITUTE
- FUNDACION INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ
- Fundación Investigación del Cáncer Universidad de Salamanca
- IRB Barcelona
- IRTA
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- Institute of Materials Science of Barcelona (ICMAB-CSIC)
- UNIVERSIDAD CATÓLICA DE MURCIA - FUNDACIÓN UNIVERSITARIA SAN ANTONIO DE MURCIA
- Universitat Autonoma de Barcelona
- Universitat de Barcelona
- Universitat de Vic (UVIC - UCC)
- University of A Coruña
- noma de Barcelona
- 4 more »
- « less
-
Field
-
: - Experience in peptide synthesis and characterisation (NMR and HPLC-MS) (maximum 2.5 points; 0.5 points/year) - Experience in cell culture maintenance (maximum 1 point; 0.5 points/year) - Experience in the use
-
and progression of MDS will allow the identification of targets for the development of new therapies that can eliminate aberrant cells and prevent or slow disease progression. Last publications: https
-
) at the Universitat de Vic – Universitat Central de Catalunya (UVic-UCC, Vic (Barcelona), Spain) invites expressions of interest for a 4-year PhD fellowship. The position is expected to start in March 2026. The project
-
? Other EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The In vivo Organ Generation by Stem Cells Group, led by Dr. Xabier Aranguren is looking
-
-oriented training itinerary. Through two separate calls, IRB-DRIVE will offer 10 four-year fellowships to outstanding doctoral candidates who will obtain their degree from the University of Barcelona (UB
-
markers, control Marfan and OKD48 mouse colonies; surgery for extraction of various organs. The candidate will join the lab of Gustavo Egea (Vascular Cell Biology Lab), which is currently comprised of 1
-
carry out the doctoral thesis for the 26/27 academic year. Adoptive cell therapyagainst cancer is a type of immunotherapy that is based on the use of agents that enhance the immune cells of the patients
-
personal investigador predoctoral en formación para el año 2024” Last year call Link (new call is expected in January 2026): https://gestiona3.madrid.org/quadrivium/convocatorias/Home
-
the participation of the calprotectin protein in them. -Performing calprotectin determinations in patient samples from the NEFRONA study. Where to apply Website https://www.irblleida.org/en/jobs/452/phd
-
Programme? Horizon Europe - ERC Is the Job related to staff position within a Research Infrastructure? No Offer Description We offer a 4-year predoctoral position to join the group of Nanoparticles